Department of Medicine and Surgery, University of Parma, Via Gramsci 14, Parma, 43126, Italy
CRC StaMeTec, Department of Biomedical, Surgical and Dental Sciences, University of Milan, Via della Commenda 10, Milan, 20122, Italy
Curr Cancer Drug Targets. 2023;23(8):663-668. doi: 10.2174/1568009623666230201092302.
Malignant pleural mesothelioma is a pathology with no effective therapy and a poor prognosis. Our previous study demonstrated an in vitro inhibitory effect on mesothelioma cell lines of both the lysate and secretome of adipose tissue-derived Mesenchymal Stromal Cells. The inhibitory activity on tumor growth has been demonstrated also : five million Mesenchymal Stromal Cells, injected , produced a significant therapeutic efficacy against MSTO-211H xenograft equivalent to that observed after the systemic administration of paclitaxel.
The objective of this study is to evaluate the efficacy of low amount (half a million) Mesenchymal Stromal Cells and micro-fragmented adipose tissues (the biological tissue from which the Mesenchymal Stromal Cells were isolated) on mesothelioma cells growth.
Tumor cells growth inhibition was evaluated and in a xenograft model of mesothelioma.
The inhibitory effect of micro-fragmented fat from adipose-tissue has been firstly confirmed on MSTO-211H cell growth. Then the efficacy against the growth of mesothelioma xenografts in mice of both micro-fragmented fat and low amount of Mesenchymal Stromal Cells has been evaluated. Our results confirmed that both Mesenchymal Stromal Cells and micro-fragmented fat, injected , did not stimulate mesothelioma cell growth. By contrast, micro-fragmented fat produced a significant inhibition of tumor growth and progression, comparable to that observed by the treatment with paclitaxel. Low amount of Mesenchymal Stromal Cells exerted only a little anticancer activity.
Micro-fragmented fat inhibited mesothelioma cell proliferation and exerted a significant control of the mesothelioma xenograft growth .
恶性胸膜间皮瘤是一种缺乏有效治疗方法和预后不良的疾病。我们之前的研究表明,脂肪组织来源的间充质基质细胞的裂解物和分泌组对间皮瘤细胞系均具有体外抑制作用。还证明了其对肿瘤生长的抑制活性:注射五百万个间充质基质细胞可产生针对 MSTO-211H 异种移植物的显著治疗功效,与紫杉醇全身给药后观察到的效果相当。
本研究旨在评估低剂量(五十万)间充质基质细胞和微碎片脂肪组织(分离间充质基质细胞的生物组织)对间皮瘤细胞生长的疗效。
评估了肿瘤细胞生长抑制作用,并在间皮瘤异种移植模型中进行了评估。
首次证实了微碎片脂肪对 MSTO-211H 细胞生长的抑制作用。然后评估了微碎片脂肪和低剂量间充质基质细胞对小鼠间皮瘤异种移植物生长的疗效。我们的结果证实,注射间充质基质细胞和微碎片脂肪均不会刺激间皮瘤细胞生长。相比之下,微碎片脂肪可显著抑制肿瘤生长和进展,与紫杉醇治疗观察到的效果相当。低剂量间充质基质细胞仅表现出轻微的抗癌活性。
微碎片脂肪抑制间皮瘤细胞增殖,并对间皮瘤异种移植物生长产生显著的控制作用。